GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Anuh Pharma Ltd

Anuh Pharma Q2 FY27 Net Profit Rs. 1,121.31 Lakhs; Promoter Reclassification Withdrawn

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 30 Oct 2026, 04:55 PM IST  ·  BSE ID: 35915f06-3431-4a5e-8c61-eb49318ac5ae
View Original BSE Filing (PDF)
💡
In Simple Terms
Anuh Pharma's profit went up by 47.29% for the quarter, and a promoter decided to stay in that group.
🤖 AI Summary
  • Anuh Pharma's Q2 FY27 net profit increased 47.29% to Rs. 1,121.31 Lakhs compared to Q2 FY26.
  • Revenue from operations for Q2 FY27 was Rs. 18,524.14 Lakhs, a 0.35% decrease year-on-year.
  • Half-year (H1 FY27) net profit rose to Rs. 2,263.80 Lakhs, up 42.25% from H1 FY26.
  • Total revenue for H1 FY27 reached Rs. 38,273.69 Lakhs, marking a 1.60% increase year-on-year.
  • A promoter group member, Nina Vijay Shah, withdrew her reclassification application and remains in the Promoter Group with 0.06% shareholding.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Profit/(Loss) after Tax (Q2 FY27)
Rs. 1,121.31 Lakhs
47.29
Revenue from operations (Q2 FY27)
Rs. 18,524.14 Lakhs
-0.35
Profit/(Loss) after Tax (H1 FY27)
Rs. 2,263.80 Lakhs
42.25
Total Revenue (H1 FY27)
Rs. 38,273.69 Lakhs
1.60
Nina Vijay Shah Shareholding
0.06
🏢 How This Affects the Company
💰
Financial Impact
Profit after tax increased by Rs. 359.06 Lakhs in Q2 FY27 year-on-year, driven by lower total expenses despite slightly reduced revenue from operations. The company's net cash from operations for the half year stood at Rs. 2,668.23 Lakhs.
⚠️
Risk Impact
The withdrawal of the reclassification request means there is no immediate change to the existing promoter structure or associated governance implications. No new or increased risks are indicated by this development.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this filing.
👤
Who Is Affected
Shareholders are generally affected by the company's financial performance. The decision by Nina Vijay Shah (0.06% shareholding) to remain in the Promoter Group maintains the existing classification of her shares.
🔍
Management Signal
The board's approval of the financial results and acknowledgment of the reclassification withdrawal indicates ongoing operational and governance management in line with regulatory requirements.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 financial results — monitor sustained profit growth and revenue trends.
Any future updates on promoter group classifications or shareholding changes.
Cash flow statement details in subsequent quarterly filings.
LOW RISK No significant new risks identified; financial results show profit growth and a promoter reclassification issue resolved.
💡 Investor Takeaway
Anuh Pharma reported a Q2 FY27 net profit of Rs. 1,121.31 Lakhs, a 47.29% increase from Q2 FY26. Half-year net profit for H1 FY27 rose 42.25% to Rs. 2,263.80 Lakhs. A promoter group member with 0.06% shareholding withdrew a reclassification request.
⚖️ Strengths & Concerns

✅ Positives

  • Profit after Tax for Q2 FY27 significantly increased by 47.29% to Rs. 1,121.31 Lakhs compared to Rs. 761.25 Lakhs in Q2 FY26.
  • Half-year Profit after Tax for H1 FY27 grew 42.25% to Rs. 2,263.80 Lakhs, up from Rs. 1,591.37 Lakhs in H1 FY26.

⚠️ Concerns

  • Revenue from operations for Q2 FY27 decreased by 0.35% to Rs. 18,524.14 Lakhs compared to Rs. 18,588.27 Lakhs in Q2 FY26.
  • Cash and cash equivalents at the end of H1 FY27 were Rs. 939.93 Lakhs, lower than the Rs. 1,955.74 Lakhs at the beginning of H1 FY26.
📅 Company Track Record
Anuh Pharma's Q2 FY27 net profit of Rs. 1,121.31 Lakhs marks an increase from the Rs. 761.25 Lakhs reported in Q2 FY26 and Rs. 1,142.49 Lakhs in Q1 FY27. H1 FY27 net profit of Rs. 2,263.80 Lakhs is up from Rs. 1,591.37 Lakhs in H1 FY26.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Anuh Pharma's net profit for Q2 FY27?
Anuh Pharma reported a Profit After Tax of Rs. 1,121.31 Lakhs for the quarter ended September 30, 2026 (Q2 FY27).
How did Anuh Pharma's Q2 FY27 net profit compare to the previous year?
The net profit for Q2 FY27 increased by 47.29% to Rs. 1,121.31 Lakhs, compared to Rs. 761.25 Lakhs in Q2 FY26.
What was Anuh Pharma's total revenue for the half year ended September 2026?
Total Revenue for the half year ended September 30, 2026 (H1 FY27) was Rs. 38,273.69 Lakhs.
What happened with the promoter reclassification request at Anuh Pharma?
Nina Vijay Shah, a shareholder with 0.06% shareholding in the Promoter Group, withdrew her application for reclassification and will continue to be part of the Promoter Group.
What was Anuh Pharma's Earnings Per Share (EPS) for Q2 FY27?
The Basic and Diluted Earnings Per Share for Q2 FY27 were Rs. 1.12 each.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.